Samitib 400mg Tablet (Imatinib) – Long Product Description

Samitib 400mg Tablet (Imatinib) is a prescription targeted anti-cancer medicine manufactured by Samarth Life Sciences Pvt. Ltd. It contains Imatinib Mesylate 400mg, a tyrosine kinase inhibitor (TKI) used to treat several types of blood cancers and certain solid tumors. Samitib works by blocking abnormal proteins that promote the uncontrolled growth of cancer cells, helping slow disease progression and improve treatment outcomes.

Each pack of Samitib 400mg Tablet contains 30 tablets, making it suitable for continuous treatment under the supervision of an oncologist or hematologist. Imatinib has transformed the treatment of cancers driven by abnormal tyrosine kinase activity and remains a standard first-line therapy for many patients.

How Samitib 400mg Tablet Works

Imatinib selectively inhibits abnormal tyrosine kinases such as BCR-ABL, KIT (CD117), and PDGFR (platelet-derived growth factor receptor). These abnormal proteins stimulate the uncontrolled growth and survival of cancer cells. By blocking their activity, Samitib helps stop cancer cell proliferation and promotes programmed cell death (apoptosis), while minimizing damage to healthy cells.

Its targeted mechanism makes Imatinib one of the most successful precision medicines used in modern oncology.

Uses of Samitib 400mg Tablet

Samitib 400mg Tablet is indicated for the treatment of:

• Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) in adults and children.
• Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL).
• Gastrointestinal Stromal Tumors (GIST) that are KIT-positive.
• Myelodysplastic/Myeloproliferative Disorders (MDS/MPD) associated with PDGFR abnormalities.
• Hypereosinophilic Syndrome (HES) and Chronic Eosinophilic Leukemia (CEL) in selected patients.
• Dermatofibrosarcoma Protuberans (DFSP) when surgical treatment is not appropriate.

The treatment plan depends on the patient’s diagnosis, genetic testing results, disease stage, and response to therapy.

Benefits of Samitib 400mg Tablet

Samitib offers several important therapeutic benefits, including:

• Targets cancer cells with high precision.
• Helps control the progression of Chronic Myeloid Leukemia (CML).
• Effective treatment for KIT-positive Gastrointestinal Stromal Tumors (GIST).
• Oral tablet for convenient once-daily administration.
• May improve long-term survival and disease control.
• Suitable for prolonged therapy under specialist supervision.
• Manufactured by Samarth Life Sciences Pvt. Ltd., a trusted pharmaceutical company.

Dosage and Administration

Samitib 400mg Tablet should be taken exactly as prescribed by an oncologist. It is usually taken once daily with a meal and a full glass of water to reduce stomach irritation. Tablets should be swallowed whole and should not be crushed or chewed unless advised by the treating physician.

The dosage may vary depending on the disease being treated, body weight, treatment response, and any side effects experienced during therapy. Regular blood tests and medical follow-up are essential throughout treatment.

Possible Side Effects

Like all anti-cancer medicines, Samitib may cause side effects, although not every patient experiences them.

Common side effects include:

• Nausea
• Vomiting
• Diarrhea
• Fatigue
• Muscle cramps
• Joint pain
• Skin rash
• Swelling around the eyes or ankles
• Headache
• Loss of appetite

Serious side effects may include:

• Severe liver problems
• Heart failure
• Fluid retention
• Severe skin reactions
• Low blood cell counts
• Gastrointestinal bleeding
• Serious infections

Seek immediate medical attention if you experience severe swelling, difficulty breathing, persistent fever, unusual bleeding, yellowing of the skin or eyes, or severe abdominal pain.

Precautions and Warnings

Before taking Samitib 400mg Tablet, inform your healthcare provider if you have:

• Liver disease
• Kidney disease
• Heart disease
• Thyroid disorders
• History of hepatitis
• Pregnancy or plans to become pregnant

Women should avoid becoming pregnant during treatment. Effective contraception is recommended during therapy and for the recommended period after the final dose. Breastfeeding should be avoided while taking Imatinib.

Storage Information

Store Samitib 400mg Tablets at room temperature below 30°C, protected from heat, moisture, and direct sunlight. Keep the tablets in their original packaging and out of the reach of children.

Why Buy Samitib 400mg Tablet from MedicineWalyDost?

At MedicineWalyDost, we provide genuine oncology medicines sourced from trusted pharmaceutical manufacturers. Samitib 400mg Tablet by Samarth Life Sciences Pvt. Ltd. is available with reliable nationwide delivery across Pakistan for hospitals, oncology clinics, and individual patients.

When you order from MedicineWalyDost, you receive:

• Genuine oncology medicines
• Competitive prices
• Nationwide delivery across Pakistan
• Secure packaging
• Professional customer support
• Assistance with medicine availability and ordering

Note: A valid prescription from a qualified oncologist or hematologist is required before purchasing Samitib 400mg Tablet.

---

Frequently Asked Questions (FAQs)

What is Samitib 400mg Tablet used for?

Samitib 400mg Tablet is used to treat Chronic Myeloid Leukemia (CML), Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL), Gastrointestinal Stromal Tumors (GIST), and certain other cancers driven by abnormal tyrosine kinases.

Who manufactures Samitib 400mg Tablet?

Samitib 400mg Tablet is manufactured by Samarth Life Sciences Pvt. Ltd.

What is the pack size?

Each pack contains 30 tablets.

How should Samitib be taken?

It is usually taken once daily with food and a full glass of water, exactly as prescribed by your oncologist.

Is a prescription required?

Yes. Samitib 400mg Tablet is a prescription-only targeted cancer medicine and should only be used under the supervision of a qualified healthcare professional.